Delivery Order SPE2DB24D2205-SPE2DB25FDUQS

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $74K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $21,884.72, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 1, 2024, and is a Firm Fixed Price Delivery Order. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $24,520.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides Tolvaptan 15 mg tablets to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for the company to supply a...
This federal contract award, valued at $13,691.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tolvaptan 15 mg tablets, a medication used to treat certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance extending to July 15, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award is for the delivery of Tolvaptan 15 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $30,520.96. The contract is a firm fixed-price delivery order with a completion date of December 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with the ID SPE2DX15D1022|SPE2DX25FVBVS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $38,084.10 fixed-price delivery order is for the supply of 4567111758 TOLVAPTAN 15 MG TABLET UD 10S, with a period of performance through February 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,749.40 firm-fixed-price contract is for the supply of TOLVAPTAN 15 MG TABLET UD 10S, a pharmaceutical product. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of medical commodities to support...
This federal contract award is for the delivery of the pharmaceutical product Tolvaptan 15 mg tablet in unit dose packaging of 10. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $42,172.02 and a completion date of December 22, 2023. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The $63,134.84 firm fixed-price contract is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen is the prime contractor and no set-aside designation was used. This contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $7,674.04 and a period of performance running through March 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,932.92 firm-fixed-price delivery order is for the supply of 4,562,627,885 units of Tolvaptan 15 mg tablets. The contract has an ultimate completion date of October 30, 2023. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUQS
    Delivery Order

This federal contract award, valued at $74,385.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of TOLVAPTAN 15 MG TABLET UD 10S.

The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided on any major subcontractors. The DLA, which is a defense agency, is the funding agency for this contract.

Generated 5/20/25, 2:25 PM